| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/19/2008 | CA2267668C Method for enhancing the efficiency of gene transfer with stem cell factor polypeptide |
| 02/19/2008 | CA2173976C Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 02/19/2008 | CA2132613C Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface |
| 02/14/2008 | WO2008019346A2 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
| 02/14/2008 | WO2008018641A1 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 02/14/2008 | WO2008018592A1 External preparation comprising prostaglandin derivative |
| 02/14/2008 | WO2008018488A1 Antibacterial agent |
| 02/14/2008 | WO2008018447A1 Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2008017658A2 Use of glucocorticoid receptor antagonists for treatment of infectious conditions |
| 02/14/2008 | WO2008017586A2 Special carbonyl-bis imino compounds for using as p2y11 receptor agonists in the treatment of immune diseases |
| 02/14/2008 | WO2008017473A2 Structure and use of 5' phosphate oligonucleotides |
| 02/14/2008 | WO2007110704A3 Macrolide compositions as therapeutic agent |
| 02/14/2008 | WO2006048781A3 IgE-RETARGETING, FUNCTION-ALTERING MOLECULES (ERFAM) FOR TREATMENT OF ALLERGIC DISEASES |
| 02/14/2008 | US20080039622 2,4-pyrimidinediamine compounds and their uses |
| 02/14/2008 | US20080039509 Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity |
| 02/14/2008 | US20080039486 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies |
| 02/14/2008 | US20080039478 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof |
| 02/14/2008 | US20080039466 2-(3-Substituted-Aryl) Amino-4-Aryl-Thiazoles As Tyrosine Kinase Inhibitors |
| 02/14/2008 | US20080039465 Triazolyl phenyl benzenesulfonamides |
| 02/14/2008 | US20080039464 Compounds Which Modulate The CB2 Receptor |
| 02/14/2008 | US20080039457 Triazolotriazines as kinase inhibitors |
| 02/14/2008 | US20080039456 4-[2-(4-nitro-phenyl)-6-oxo-4-thioxo-6H-1-oxa-3b,5-diaza-cyclopenta[a]pentalen-5-yl]-butyric acid, used for inhibiting heparin-binding proteins and in the treatment of pancreatic cancer; anticarcinogenic agents |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 02/14/2008 | US20080039444 Antiallergens; antiinflammatory agents; rhinitis |
| 02/14/2008 | US20080039439 Alpha2C adrenoreceptor agonists |
| 02/14/2008 | US20080039426 2-(4-fluoro-2-methylphenylamino)-1,6-dimethyl-7-[3-(4-methyl-4-oxo-4 lambda 5[1,4]azaphosphinan-1-yl)-propenyl]-1,8-dihydro-imidazo[4,5-h]isoquinolin-9-one; anticancer agents, antiinflammatory agents, antiviral agents, anti-thromboembolic agents, as well as for treating autoimmune disease |
| 02/14/2008 | US20080039416 Methods for Treating Disease by Modulating an Osmotic Stress Pathway |
| 02/14/2008 | US20080039401 For allergy such as asthma; modulating interleukin (IL)-9 expression |
| 02/14/2008 | US20080039393 Metal-binding therapeutic peptides |
| 02/14/2008 | US20080039377 Composition Comprising a Jnk Inhibitor and Cyclosporin |
| 02/14/2008 | US20080039369 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
| 02/14/2008 | US20080039364 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 02/14/2008 | US20080038353 Polymer Based Nano-Carriers For The Solubilization And Delivery Of Hydrophobic Drugs |
| 02/14/2008 | US20080038349 Peptide-Pna Chimera Targeting Inducible Nitric Oxide Synthetase |
| 02/14/2008 | US20080038329 T-cell activating agent |
| 02/14/2008 | US20080038319 Stimulating protective antibodies against enterotoxigenic Escherichia coli; carbonated beverages |
| 02/14/2008 | US20080038297 Genetic adjuvants for viral vaccines |
| 02/14/2008 | US20080038291 Method to reduce the physiologic effects of drugs on mammals |
| 02/14/2008 | US20080038286 Glycosylated polypeptides produced in yeast mutants and methods of use thereof |
| 02/14/2008 | US20080038284 Human Immunodeficiency Virus Vaccine |
| 02/14/2008 | US20080038281 Model membrane systems |
| 02/14/2008 | US20080038275 Method for the treatment of multiple sclerosis |
| 02/14/2008 | US20080038273 Preventing CD28 binding to B7 by monovalent fragments antibody called CD28.3 of which exhibit sufficient affinity for the antigen so that they can be used, in vitro or in vivo, to block the CD28 receptor without activation of this receptor; autoimmune diseases; transplant rejection |
| 02/14/2008 | US20080038272 binds highly specifically and/or selectively to human receptors of the Frizzled family; hybridoma cell that produces the antibody |
| 02/14/2008 | US20080038264 Compositions and methods for the treatment of immune related diseases |
| 02/14/2008 | US20080038252 Histamine-Containing Composition for the Treatment of Allergic Diseases |
| 02/14/2008 | US20080038251 MN/CA IX and MAPK inhibition |
| 02/14/2008 | US20080038250 Profilin and related immunomodulatory ligands |
| 02/14/2008 | US20080038248 Proteins Ligands For Nkg2d And Ul16 Receptors And Uses Thereof |
| 02/14/2008 | US20080038237 Trojan horse immunotherapy |
| 02/14/2008 | US20080038235 Methods for regulating T cell subsets by modulating transcription factor activity |
| 02/14/2008 | US20080038234 Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair |
| 02/14/2008 | US20080038231 Processing procedure for peripheral blood stem cells |
| 02/14/2008 | US20080038223 WSX-1/P28 as a target for anti-inflammatory responses |
| 02/14/2008 | US20080038205 Novel dermatophagoides proteins |
| 02/14/2008 | DE102006037920A1 Spezielle Carbonylbisimino-Verbindungen zur Behandlung von Immunerkrankungen Carbonylbisimino specific compounds for the treatment of immune diseases |
| 02/14/2008 | CA2660232A1 Structure and use of 5' phosphate oligonucleotides |
| 02/14/2008 | CA2659599A1 Amino alcohol derivative and immunosuppressive agent having same as an active ingredient |
| 02/14/2008 | CA2659598A1 Amino phosphate derivative and s1p receptor modulator having same as an active ingredient |
| 02/14/2008 | CA2658016A1 Use of glucocorticoid receptor antagonists for treatment of infectious conditions |
| 02/13/2008 | EP1887016A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| 02/13/2008 | EP1887008A1 Thienotriazolodiazepine compound and a medicinal use thereof |
| 02/13/2008 | EP1887007A2 Novel compounds |
| 02/13/2008 | EP1885755A2 Anti-cd19 antibody therapy for autoimmune disease |
| 02/13/2008 | EP1885752A2 Modified leukocyte ig-like receptor family members (lir's) with increased affinity for class i mhc and their uses in modulating t cell activation |
| 02/13/2008 | EP1885717A1 Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases |
| 02/13/2008 | EP1885716A1 Thiazole derivatives and use thereof |
| 02/13/2008 | EP1885709A2 Benzofuran derivatives with therapeutic activities |
| 02/13/2008 | EP1885377A2 Structured phospholipids for treating autoimmune and neurodegenerative diseases |
| 02/13/2008 | EP1615656B9 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | EP1470148A4 Double-stranded oligonucleotides |
| 02/13/2008 | EP1454137B1 Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations |
| 02/13/2008 | EP1441701B1 Montelukast granule formulation |
| 02/13/2008 | EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 02/13/2008 | EP1105467B9 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 02/13/2008 | EP0837928B1 Recombinant poxvirus - cytomegalovirus compositions and uses |
| 02/13/2008 | CN101124318A Novel strain conferring anti-disease properties to host and bacterial cell composition |
| 02/13/2008 | CN101124227A Imidazo[1,2-a]pyrazin-8-ylamines useful as modulators of kinase activity |
| 02/13/2008 | CN101124213A Sulfonyl amino cyclic derivatives and use thereof as mmp inhibitors |
| 02/13/2008 | CN101124014A Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 02/13/2008 | CN101123968A Methods for treating mast cell disorders |
| 02/13/2008 | CN101123956A Use of PPAR agonists to treat ruminants |
| 02/13/2008 | CN101121749A Gamma-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 02/13/2008 | CN101121662A Chlorogenic acid ester derivative, preparation method and application thereof in pharmaceutical preparation |
| 02/13/2008 | CN101121020A Anti-gp39 antibodies and its uses |
| 02/13/2008 | CN101120986A Body-clearing itching-relieving liquid |
| 02/13/2008 | CN101120970A Phenolic extract of duchesnea indica focke, preparation method and application thereof |
| 02/13/2008 | CN101120955A Enteric coated preparation containing glossy ganoderma spore powder active ingredient |
| 02/13/2008 | CN101120915A Dexamethasone sodium phosphate injection |
| 02/13/2008 | CN101120776A Method for extracting beta-glucan from cereal bran using membrane separation technology |
| 02/13/2008 | CN100368411C 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 02/13/2008 | CN100368398C 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| 02/13/2008 | CN100368394C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 02/13/2008 | CN100368020C Compositions for stimulating cytokine secretion and inducing an immune response |
| 02/13/2008 | CN100367975C Supercritical CO2 extraction method of ganderoma lucium oil |
| 02/13/2008 | CN100367973C Drying material and producing method thereof |
| 02/13/2008 | CN100367955C Compsn. of medication of containing creat lactone of triacetyl and usages |